29 Apr 2015 14:55
LONDON, April 8 (Reuters) - British biotech group Silence Therapeutics has raised 38.9 million pounds ($58.2 million) by selling two tranches of new shares at 240 pence each to develop its genetic medicine platform. The company, whose technology works by interfering with RNA molecules, said
Read more